These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 4293637

  • 1. [The behavior of serum-cholesterins in patients with multiple sclerosis].
    Lienhardt M.
    Schweiz Arch Neurol Neurochir Psychiatr; 1966; 98(2):258-70. PubMed ID: 4293637
    [No Abstract] [Full Text] [Related]

  • 2. Optic neuritis and its relationship to disseminated sclerosis.
    Landy PJ, Ohlrich GD.
    Proc Aust Assoc Neurol; 1970; 7():67-70. PubMed ID: 4328431
    [No Abstract] [Full Text] [Related]

  • 3. [The behavior of serum immunoglobulins in multiple sclerosis during anti-inflammatory therapy].
    Paltrinieri E, Giovannucci M.
    Acta Neurol (Napoli); 1969; 24(4):613-25. PubMed ID: 4101181
    [No Abstract] [Full Text] [Related]

  • 4. [Effect of clinical exacerbations and ACTH therapy on the level of lipids in blood serum of patients with sclerosis].
    Szajbel W, Cendrowski W, Waszkiewicz E, Niedzielska K.
    Neurol Neurochir Pol; 1968; 2(6):691-7. PubMed ID: 4303589
    [No Abstract] [Full Text] [Related]

  • 5. [Multiple sclerosis].
    Palo J.
    Duodecim; 1973 Aug; 89(22):1479-96. PubMed ID: 4358206
    [No Abstract] [Full Text] [Related]

  • 6. Multiple sclerosis: etiologic and diagnostic significance of measles virus antibodies in the cerebrospinal fluid and serum.
    Cendrowski W, Niedzielska K.
    Schweiz Arch Neurol Neurochir Psychiatr; 1974 Aug; 114(2):215-28. PubMed ID: 4421491
    [No Abstract] [Full Text] [Related]

  • 7. Plasma zinc levels in multiple sclerosis.
    Wong EK, Enomoto H, Leopold IH, Fleischer EB, Schoon DV, Fender D, Tucker HG, Adamson B, Kladde L, Kazan D, Nudleman K.
    Metab Pediatr Ophthalmol; 1980 Aug; 4(1):3-8. PubMed ID: 7442341
    [No Abstract] [Full Text] [Related]

  • 8. Changes in serum immunoglobulin concentrations in patients with multiple sclerosis during the treatment with ACTH.
    Maciejek Z, Rebeś Z, Kubasiewicz B.
    Arch Immunol Ther Exp (Warsz); 1981 Aug; 29(2):141-4. PubMed ID: 6272663
    [Abstract] [Full Text] [Related]

  • 9. [Clinical phenomena in early and late-onset multiple sclerosis].
    Marforio S.
    Minerva Med; 1977 Feb 04; 68(6):405-12. PubMed ID: 190562
    [No Abstract] [Full Text] [Related]

  • 10. [Trials of Synacthen in multiple sclerosis].
    Badino R.
    Riv Neurol; 1970 Feb 04; 40(3):139-64. PubMed ID: 4321924
    [No Abstract] [Full Text] [Related]

  • 11. [Initial results of the determination of HDL-cholesterol in patients with cerebrovascular strokes and multiple sclerosis (the significance of the ratio between HDL-cholesterol and total cholesterol)].
    Opavský J, Bartek J.
    Acta Univ Palacki Olomuc Fac Med; 1982 Feb 04; 102():299-310. PubMed ID: 6242584
    [No Abstract] [Full Text] [Related]

  • 12. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C.
    Rev Neurol (Paris); 1973 Jan 04; 128(1):72-7. PubMed ID: 4367744
    [No Abstract] [Full Text] [Related]

  • 13. [The therapeutic effect of corticosteroids on the symptoms and course of multiple sclerosis].
    Mayer K, Trübestein G, Diefenbach C.
    Med Welt; 1970 Mar 07; 10():392-5. PubMed ID: 4314318
    [No Abstract] [Full Text] [Related]

  • 14. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M, Zakrzewska I, Klem J, Puczkowski S, Strzelczyk M, Czernicki J, Chmielewski H.
    Pol J Pharmacol; 1995 Mar 07; 47(6):525-30. PubMed ID: 8868375
    [Abstract] [Full Text] [Related]

  • 15. [Cyclophosphamide in the therapy of multiple sclerosis].
    Salvatores U, Majeron M, Mascetti A.
    Riv Sper Freniatr Med Leg Alien Ment; 1972 Feb 29; 96(1):163-84. PubMed ID: 4337775
    [No Abstract] [Full Text] [Related]

  • 16. Influence of ACTH on activity of some granulocytic proteases in patients with multiple sclerosis.
    Czernicki J, Tchórzewski H, Chmielewski H.
    Arch Immunol Ther Exp (Warsz); 1979 Feb 29; 27(3):345-9. PubMed ID: 224833
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis].
    Hamel-Puskarić N, Arko K, Dupelj M, Novak Z, Barac B, Czukor M.
    Neuropsihijatrija; 1969 Feb 29; 17(1):51-70. PubMed ID: 4191305
    [No Abstract] [Full Text] [Related]

  • 18. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W.
    Med Welt; 1969 Nov 29; 48():2636-49. PubMed ID: 4318400
    [No Abstract] [Full Text] [Related]

  • 19. Serum cholesterol in health and disease.
    Civin WH.
    Ann Clin Lab Sci (1971); 1972 Nov 29; 2(5):367-75. PubMed ID: 4563228
    [No Abstract] [Full Text] [Related]

  • 20. A serum lymphotoxic factor in multiple sclerosis.
    Stjernholm R, Wheelock EF, van den Noort S.
    Neurology; 1970 Apr 29; 20(4):389. PubMed ID: 5535012
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.